290 results
8-K
EX-99.2
MRK
Merck & Co Inc
25 Apr 24
Merck Announces First-Quarter 2024 Financial Results
6:41am
amounts due to rounding.
(1) Europe represents all European Union countries, the European Union accession markets and the United Kingdom.
MERCK
8-K
EX-99.1
MRK
Merck & Co Inc
25 Apr 24
Merck Announces First-Quarter 2024 Financial Results
6:41am
is currently under review in the European Union and is being evaluated in ongoing Phase 3 trials in additional PAH patient populations.
In oncology
8-K
EX-99.2
utdp n7mxqvtuq9j9
1 Feb 24
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
6:39am
8-K
EX-99.1
jzxz0h1w4q3nvo2mlg
26 Oct 23
Merck Announces Third-Quarter 2023 Financial Results
6:38am
8-K
EX-99.2
1676e9vb1
26 Oct 23
Merck Announces Third-Quarter 2023 Financial Results
6:38am
8-K
EX-99.1
4br90 bkqgh26kp
1 Aug 23
Merck Announces Second-Quarter 2023 Financial Results
6:46am
8-K
EX-99.2
2c9 zrsdtu0pnclo3a
1 Aug 23
Merck Announces Second-Quarter 2023 Financial Results
6:46am
424B5
acedgt1ux7199tq yia
10 May 23
Prospectus supplement for primary offering
4:27pm
424B5
8z70tdczl8quhswrfoqb
8 May 23
Prospectus supplement for primary offering
8:17am